NCT00229307

Completed

Prolonged Exposure (PE) Treatment for Post Traumatic Stress ...

Sheba Medical Center Source

Compare

Other study identifiers

Sponsor study identifier

SHEBA-05-3709-JZ-CTIL

Study Type

interventional

Actual enrollment (reported)

39

Locations

1 country

Sites

1

Timeline

Study Start

December 2005

Date type not reported

This date has not been verified as actual or estimated.

Primary Completion

December 2010

Actual (reported)

Study Completion

December 2010

Actual (reported)

Brief Summary

Comparing the efficacy of 40 minutes PE treatment to 20 minutes of the same treatment

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: completed
Actual enrollment (reported): 39 participants
Study completion date: December 2010
Actual (reported)
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Some registry-reported names shown below are not yet linked in this graph.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

First Submitted
September 28, 2005
Actual (reported)
First Posted
September 29, 2005
Actual (reported)
Study Start
December 2005
Date type not reported
This date has not been verified as actual or estimated.
Primary Completion
December 2010
Actual (reported)
Study Completion
December 2010
Actual (reported)

Last Updated: January 29, 2013
Status Verified: January 2013
Last Update Submitted: January 26, 2013

Conditions

PTSD

Keywords

Post traumatic stress disorder

Outcome Measures

Primary Outcomes (1)

PSS-i
15 weeks and 1-year follow-up

Study Arms (2)

1

ACTIVE COMPARATOR

Behavioral: Prolonged Exposure (PE) therapy

2

ACTIVE COMPARATOR

Behavioral: Prolonged Exposure (PE) therapy

Interventions

Prolonged Exposure (PE) therapyBehavioral

20 minutes exposure

1

Prolonged Exposure (PE) therapyBehavioral

40 minutes exposure

2

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age18 Years - 65 Years

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

PTSD

You may not qualify if:

Sponsors & Collaborators

Sheba Medical Center
Governmentlead

Study Sites (1)

Chaim Sheba Medical Center

Ramat Gan, 52621, Israel

MeSH Terms

Conditions

Stress Disorders, Post-Traumatic

Interventions

Therapeutics

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental Disorders

Study Officials

Nitza Nacasch, MD
Sheba Medical Center
STUDY CHAIR
Joseph Zohar, MD
Sheba Medical Center
PRINCIPAL INVESTIGATOR

Enrollment

39 participants (actual enrollment reported by the registry).

Study Design

Study Type: interventional
Phase: not applicable
Allocation: RANDOMIZED
Masking: SINGLE
Who Masked: OUTCOMES ASSESSOR
Purpose: TREATMENT
Intervention Model: PARALLEL
Sponsor Type: OTHER GOV
Responsible Party: SPONSOR

Study Record Dates

First Submitted

September 28, 2005

First Posted

September 29, 2005

Study Start

December 2005

Date type not reported

This date has not been verified as actual or estimated.

NCT01039766

The Efficacy of a Single Dose of Intranasal Oxytocin in the Prevention of Post Traumatic Stress Disorder (PTSD)

Not ApplicableUnknown

NCT00474305

Virtual Reality Prolonged Exposure (PE) for Bus Bomb Survivors

Not ApplicableUnknown

NCT00146900

Prevention of Post Traumatic Stress Disorder by Early Treatment

Not ApplicableCompleted

NCT00784771

Hypnotherapeutic Olfactory Conditioning for Posttraumatic Stress Disorder (PTSD)

Not ApplicableCompleted

NCT00736021

Treatment of Post-traumatic Stress Disorder With High Doses of Escitalopram

Not ApplicableCompleted

NCT00364910

Safety and Efficacy of Cognitive Behavior Therapy for People With Post-traumatic Stress and Cardiovascular Illness

Not ApplicableCompleted

Psychotic symptoms

Dissociation

Drug or Alcohol dependence

Contact the study team to confirm eligibility.

Primary Completion

December 2010

Actual (reported)

Study Completion

December 2010

Actual (reported)

Last Updated

January 29, 2013

Record last verified: 2013-01

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT00229307
Data provider: ClinicalTrials.gov
Source updated: 2013-01-29
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:29:49 UTC

Locations

IL(1)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

First Submitted

First Posted

Study Start

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Study Arms (2)

1

2

Interventions

Eligibility Criteria

You may qualify if:

You may not qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Interventions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

Source record

Locations